LPTX icon

Leap Therapeutics
LPTX

Overview Fund Activity

50 hedge funds and large institutions have $55M invested in Leap Therapeutics in 2020 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 9 closing their positions.

Holders
50
Holders Change
+9
Holders Change %
+21.95%
% of All Funds
0.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
13
Reduced
10
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PIM
1
Platinum Investment Management
Australia
$2.4M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$4.27M
3
AG
3
Artal Group
Luxembourg
$6.75M
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$672K
5
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$278K

Top Sellers

1
SCM
1
Sio Capital Management
New York
$0
2
JGC
2
J. Goldman & Co
New York
$0
3
Verition Fund Management
3
Verition Fund Management
Connecticut
$0
4
Renaissance Technologies
4
Renaissance Technologies
New York
$744K
5
6CM
5
683 Capital Management
New York
$452K
Name Holding Trade Value Shares
Change 		Shares
Change %
Squarepoint
51
Squarepoint
New York
– -$125K -6,316 Closed
OWP
52
Old Well Partners
North Carolina
– -$76K -3,814 Closed
RJA
53
Raymond James & Associates
Florida
– -$66K -3,310 Closed
GC
54
Gratus Capital
Georgia
– -$50K -2,500 Closed
TRCT
55
Tower Research Capital (TRC)
New York
– -$6K -320 Closed
Federated Hermes
56
Federated Hermes
Pennsylvania
– -$1K -49 Closed
1 2
3